Dr. Ivan Andres Buitrago Guevara, MD

Dr. Buitrago Guevara practices at Jackson North Medical Center - Nuclear Medicine - HOPD in North Miami Beach, Florida.

Dr. Buitrago Guevara's NPI, 1942525605, was assigned on April 6, 2010. Dr. Buitrago Guevara graduated from Universidad del Valle Health Sciences in 2003. Dr. Buitrago Guevara holds Florida license ME119321.

Dr. Buitrago Guevara's primary practice is Jackson North Medical Center - Nuclear Medicine - HOPD, at 160 Nw 170th Street, North Miami Beach, FL 33169.

Dr. Buitrago Guevara's primary practice is Jackson North Medical Center - Nuclear Medicine - HOPD in North Miami Beach, Florida. Dr. Buitrago Guevara is also affiliated with Jackson Memorial Hospital. The medical group on file is Jackson Health System. Dmand AI also links Dr. Buitrago Guevara to 1 more hospital, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Buitrago Guevara practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Buitrago Guevara's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Buitrago Guevara is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Buitrago Guevara is licensed in Florida.

Dmand AI lists atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic hypertension, coronary artery disease, endocarditis, heart failure and high cholesterol among the conditions Dr. Buitrago Guevara treats.

CMS data shows 1,026 Medicare services from Dr. Buitrago Guevara across 11 procedure codes in 2024, for 601 Medicare patients. Medicare paid $34,032 for them.

CMS counts 601 Medicare patients who saw Dr. Buitrago Guevara in 2024. The largest group is 85 and over, with 183 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 58% are also on Medicaid. Their average risk score is 2.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Buitrago Guevara's median patient age at 64, with 53% women.

In 2024, Dr. Buitrago Guevara wrote 1,550 Medicare Part D claims for 238 patients. 77% of them were for generic drugs. CMS names the drug for 1,380 of them, across 33 drugs with 11 or more claims each, at $331,334 in total drug cost. In 2023, CMS named 1,165 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Buitrago Guevara for performance year 2024, reported as part of a group. Dr. Buitrago Guevara accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Buitrago Guevara as offering telehealth.

CMS Open Payments shows 342 general payments to Dr. Buitrago Guevara from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,647.

Dr. Buitrago Guevara graduated from Universidad del Valle Health Sciences in 2003.

Dr. Buitrago Guevara is in network with 18 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.